Rawat Vinita, Singhai Monil, Verma Pankaj Kumar
Department of Microbiology, Government Medical College, Haldwani, Nainital, Uttarakhand, India.
J Lab Physicians. 2013 Jan;5(1):21-5. doi: 10.4103/0974-2727.115918.
Resistance to broad spectrum beta-lactams mediated by extended spectrum β-lactamase (ESBL), AmpC, and metallobetalactamase (MBLs) enzymes are an increasing problem worldwide. The study was aimed to detect occurrence rate and to evaluate different substrates and inhibitors by disc combination method for detecting varying degree of β-lactamase enzymes and their co-production.
A disc panel containing imipenem (IMP), IMP/EDTA, ceftazidime (CA), ceftazidime-tazobactum (CAT), CAT/cloxacillin (CLOX), ceftazidime-clavulanic acid (CAC), CAC/CLOX, cefoxitin (CN), and CN/CLOX in a single plate was used to detect presence of ESBLs, AmpC, and MBLs and/or their co-existence in 184 consecutive, nonrepetitive, clinical isolates of Enterobacteriace (n = 96) and Pseudomonas spp. (n = 88) from pus samples of hospitalized patients, resistant to 3(rd) generation cephalosporins.
Out of a total of 96 clinical isolates of Enterobacteriaceae, 18.7, 20.8, and 27% were pure ESBL, AmpC, and MBL producers, respectively. ESBL and AmpC were co-produced by 25% isolates. Among 88 Pseudomonas spp. 38.6, 13, and 6% were pure MBL, ESBL, and AmpC producers, respectively. ESBL/AmpC and MBL/AmpC co-production was seen in 20% and 18% isolates, respectively. Among ESBL and AmpC co-producers, CA/CAC/CLOX disc combination (DC) missed 7 of the 24 ESBL producers in Enterobacteriace and 4 of the 18 ESBL in Pseudomonas spp., which were detected by CA/CAT/CLOX DC. No mechanism was detected among 8.3% Enterobacteriaceae and 2.3% Pseudomonas isolates.
Diagnostic problems posed by co-existence of different classes of β-lactamases in a single isolate could be solved by disc combination method by using simple panel of discs containing CA, CAT, CAT/CLOX, IMP, and IMP/EDTA.
由超广谱β-内酰胺酶(ESBL)、AmpC酶和金属β-内酰胺酶(MBL)介导的对广谱β-内酰胺类抗生素的耐药性在全球范围内日益严重。本研究旨在检测其发生率,并通过纸片联合法评估不同底物和抑制剂,以检测不同程度的β-内酰胺酶及其共产生情况。
使用一个平板上包含亚胺培南(IMP)、IMP/EDTA、头孢他啶(CA)、头孢他啶/他唑巴坦(CAT)、CAT/氯唑西林(CLOX)、头孢他啶/克拉维酸(CAC)、CAC/CLOX、头孢西丁(CN)和CN/CLOX的纸片组合,检测184株连续、非重复的临床分离株中ESBLs、AmpC和MBLs的存在情况及/或它们的共存情况,这些分离株来自住院患者脓液样本中对第三代头孢菌素耐药的肠杆菌科细菌(n = 96)和假单胞菌属细菌(n = 88)。
在总共96株肠杆菌科临床分离株中,分别有18.7%、20.8%和27%是单纯ESBL、AmpC和MBL产生菌。25%的分离株同时产生ESBL和AmpC。在88株假单胞菌属细菌中,分别有38.6%、13%和6%是单纯MBL、ESBL和AmpC产生菌。分别有20%和18%的分离株同时产生ESBL/AmpC和MBL/AmpC。在同时产生ESBL和AmpC的菌株中,CA/CAC/CLOX纸片组合(DC)在肠杆菌科的24株ESBL产生菌中漏检了7株,在假单胞菌属的18株ESBL产生菌中漏检了4株,而CA/CAT/CLOX DC检测到了这些菌株。在8.3%的肠杆菌科细菌和2.3%的假单胞菌属分离株中未检测到耐药机制。
通过使用包含CA、CAT、CAT/CLOX、IMP和IMP/EDTA的简单纸片组合的纸片联合法,可以解决单个分离株中不同类型β-内酰胺酶共存所带来的诊断问题。